Exothera will manufacture Meissa’s MV-012-968 vaccine candidate under CGMP regulations to supply Phase 2 clinical trials
This trial is a multi-national, phase 2/3, open-label, randomized, controlled clinical study of utidelone injectable
The randomised, multi-centre, evaluator blinded, parallel group, active controlled Phase 3 trial is being led by Lanhzou Biotechnique Development
Lucid-MS is a new drug candidate for the treatment of multiple sclerosis
Biopharma can benefit from the critical enablers of innovation in the private healthcare system in India
Astellas stands on the forefront of healthcare change to turn innovative science into value for patients
China has the highest number of clinical trials that were initiated in NAFLD in the APAC region over the past decade.
This clinical study aims to evaluate the efficacy of JAB-21822 in combination with cetuximab in patients with KRAS G12C-mutated colorectal cancer.
This clinical study will inform operational logistics and use of AV7909 should an anthrax emergency occur.
Results demonstrated a 64.5% confirmed objective response rate in patients treated with investigational combination of enfortumab vedotin and pembrolizumab
Subscribe To Our Newsletter & Stay Updated
